Search research articles
Contact Us
Filters
Showing results (91-100 of 178) with videos related to
Page
of 18
Sort By:
Cancer Research
|
March 1, 1982
Collateral sensitivity of 6-mercaptopurine-resistant sublines of P388 and L1210 leukemia to the new purine antagonists, 5-carbamoyl-1H-imidazol-4-yl piperonylate and 4-carbamoylimidazolium 5-olate
M Inaba, M Fukui, N Yoshida, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
September 1, 1994
[The mechanism of potentiation of the antitumor effect of 5-fluorouracil by methionine-free intravenous amino acid solution (AO-90) in rats]
Y Hibino, Y Kawarabayashi, H Kohri, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1980
Inhibition of murine colon adenocarcinomas and Lewis lung carcinoma by 1-hexylcarbamoyl-5-fluorouracil
T Tsuruo, H Iida, K Naganuma, et al.
Anti-Cancer Drugs
|
February 1, 1995
In vitro and in vivo antitumor activity of the interferon inducer bropirimine
M Shimizu, F Oh-Hashi, S Tsukagoshi, et al.
Cancer Research
|
August 1, 1976
Antitumor activities of newly synthesized N4-acyl-1-beta-D-arabinofuranosylcytosine
M Aoshima, S Tsukagoshi, Y Sakurai, et al.
The Journal of Antibiotics
|
September 1, 1981
Inhibition of lymph node metastasis of P388 leukemia by bestatin in mice
T Tsuruo, K Naganuma, H Iida, et al.
Gan
|
December 1, 1981
Comparison of the hematologic toxicity of 7-N-(p-hydroxyphenyl),-mitomycin C and mitomycin C
T Kobayashi, M Inaba, S Tsukagoshi, et al.
Cancer Research
|
August 1, 1977
N4-Behenoyl-1-beta-D-arabinofuranosylcytosine as a potential new antitumor agent
M Aoshima, S Tsukagoshi, Y Sakurai, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
October 1, 1985
[Antitumor activities of orally administered 4-carbamoylimidazolium-5-olate (SM-108)]
M Nakamura, M Fukui, S Morisada, et al.
Journal of Pharmacobio-Dynamics
|
October 1, 1980
Antitumor efficacies of aclacinomycin A by oral administration
S Tsukagoshi, T Tsuruo, T Yamori, et al.
Page
of 18
Search research articles
Search
Showing results (91-100 of 178) with videos related to
Sort By:
Page
of 18
Cancer Research
|
March 1, 1982
Collateral sensitivity of 6-mercaptopurine-resistant sublines of P388 and L1210 leukemia to the new purine antagonists, 5-carbamoyl-1H-imidazol-4-yl piperonylate and 4-carbamoylimidazolium 5-olate
M Inaba, M Fukui, N Yoshida, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
September 1, 1994
[The mechanism of potentiation of the antitumor effect of 5-fluorouracil by methionine-free intravenous amino acid solution (AO-90) in rats]
Y Hibino, Y Kawarabayashi, H Kohri, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1980
Inhibition of murine colon adenocarcinomas and Lewis lung carcinoma by 1-hexylcarbamoyl-5-fluorouracil
T Tsuruo, H Iida, K Naganuma, et al.
Anti-Cancer Drugs
|
February 1, 1995
In vitro and in vivo antitumor activity of the interferon inducer bropirimine
M Shimizu, F Oh-Hashi, S Tsukagoshi, et al.
Cancer Research
|
August 1, 1976
Antitumor activities of newly synthesized N4-acyl-1-beta-D-arabinofuranosylcytosine
M Aoshima, S Tsukagoshi, Y Sakurai, et al.
The Journal of Antibiotics
|
September 1, 1981
Inhibition of lymph node metastasis of P388 leukemia by bestatin in mice
T Tsuruo, K Naganuma, H Iida, et al.
Gan
|
December 1, 1981
Comparison of the hematologic toxicity of 7-N-(p-hydroxyphenyl),-mitomycin C and mitomycin C
T Kobayashi, M Inaba, S Tsukagoshi, et al.
Cancer Research
|
August 1, 1977
N4-Behenoyl-1-beta-D-arabinofuranosylcytosine as a potential new antitumor agent
M Aoshima, S Tsukagoshi, Y Sakurai, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
October 1, 1985
[Antitumor activities of orally administered 4-carbamoylimidazolium-5-olate (SM-108)]
M Nakamura, M Fukui, S Morisada, et al.
Journal of Pharmacobio-Dynamics
|
October 1, 1980
Antitumor efficacies of aclacinomycin A by oral administration
S Tsukagoshi, T Tsuruo, T Yamori, et al.
Page
of 18